All terms in MESH
| Label | Id | Description |
|---|---|---|
| Molecular Mechanisms of Pharmacological Action | D045504 | [Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY.] |
| Antipain | D000976 | [An oligopeptide produced by various bacteria which acts as a protease inhibitor.] |
| Antiparasitic Agents | D000977 | [Drugs used to treat or prevent parasitic infections.] |
| Anti-Infective Agents | D000890 | [Generically, any agent that destroys microbes. However, usage of the term is increasingly being confined to agents that prevent or reduce the transmission of SEXUALLY TRANSMITTED DISEASES., Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.] |
| Antiparkinson Agents | D000978 | [Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.] |
| Anti-Dyskinesia Agents | D018726 | [Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.] |
| alpha-2-Antiplasmin | D000979 | [A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.] |
| Glycoproteins | D006023 | [Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.] |
| Serpins | D015843 | [A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES.] |
| Antiplatyhelmintic Agents | D000980 | [Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.] |
| Anthelmintics | D000871 | [Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.] |
| Antiprotozoal Agents | D000981 | [Substances that inhibit the SCHIZONTS stage of protozoa. There is particular interest in them as ANTIMALARIALS., Substances that are destructive to protozoans.] |
| Antipruritics | D000982 | [Agents, usually topical, that relieve itching (pruritus).] |
| Dermatologic Agents | D003879 | [Drugs used to treat or prevent skin disorders or for the routine care of skin.] |
| Antipyrine | D000983 | [An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)] |
| Pyrazolones | D047069 | [Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.] |
| Antisepsis | D000985 | [The destruction of germs causing disease.] |
| Infection Control | D017053 | [Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.] |
| Antisickling Agents | D000986 | [Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.] |
| Hematologic Agents | D006401 | [Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.] |